The FDA has cleared Tandem’s Control-IQ technology as the first ever AID specifically for use in pregnancies complicated by type 1 diabetes.

Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development-stage biotech company specializing in the development of innovative intranasal ...

As pharma manufacturers prioritize U.S. supply chain resilience, highlights include high-speed isolator filling lines for ...

ESTERO, FL / ACCESS Newswire / April 27, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug deli ...

ESTERO, FL / ACCESS Newswire / April 27, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a ...

Backed by a wide network of partnerships supported by the Emirates Drug Establishment (EDE), this position demonstrates the ...

Florida hospital leaders were in Washington this week, calling on federal partners to support policies and investments that make health care more accessible and affordable for Floridians and ...

Oligonucleotide (oligo) therapies have been in development for decades. Recent advances in molecular design, chemistry, ...

Explore the economic and logistical factors driving prescription drug shortages and their impact on global patient care.

Drawing on insights from the global regulatory landscape, industry trends, and direct feedback from customers, Dr. Di Wu ...

Amazon offers weight loss drug pricing and delivery to about 3,000 cities, including Seattle, and plans on expanding to 4,500 ...